nChroma Bio, Inc.
1Patents
1Active
1Granted
52Portfolio score
Filing activity: Jul 2, 2024 → Jul 2, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12390538B2 | Compositions and methods for epigenetic regulation of HBV gene expression | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.